Skip to Content

Gestational Age Tied to Attention-Deficit Symptoms With Down Syndrome

FRIDAY, Dec. 11, 2020 -- Gestational age is associated with symptoms of attention‑deficit/hyperactivity disorder (ADHD) in late‑preterm to full‑term children and adolescents with Down syndrome, according to a study published online Nov. 23 in Scientific Reports.

Laura del Hoyo Soriano, from the University of California, Davis, in Sacramento, and colleagues investigated the influence of gestational age in later symptoms of ADHD in 105 individuals (56 females; aged 6 to 18 years) with Down syndrome who were born at ≥35 weeks of gestation.

The researchers found that gestational age was related to inattentive and hyperactive/impulsive symptoms in children and adolescents with Down syndrome, with earlier gestational age linked to increased ADHD symptoms later in childhood. These findings parallel a similar correlation in the general population.

"Gestational age should be addressed when considering symptoms of attention-deficit/hyperactivity disorder, as it may have implications for early interventions," the authors write. "More attention is needed toward the advancement of care and follow-up for infants with Down syndrome who are born even late preterm or early term."

Abstract/Full Text

© 2021 HealthDay. All rights reserved.

Posted: December 2020

Read this next

Exercise Key to Lowering Risk for Gestational Diabetes

THURSDAY, Jan. 14, 2021 -- Exercise during the first trimester of pregnancy reduces the risks for abnormal glucose screening and gestational diabetes mellitus (GDM), according to...

One in Four Women With ADHD Attempts Suicide

MONDAY, Jan. 11, 2021 -- Adults with attention-deficit/hyperactive disorder (ADHD) have higher rates of suicide attempts than the general population, according to a study...

Machine Learning Models Can Predict Gestational Diabetes

THURSDAY, Jan. 7, 2021 -- Machine learning (ML) models are highly accurate for predicting gestational diabetes mellitus (GDM) in early pregnancy in a Chinese population, according...

More News Resources

Subscribe to our Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.